Zi-Yue Wan

560 total citations
17 papers, 457 citations indexed

About

Zi-Yue Wan is a scholar working on Nephrology, Molecular Biology and Pharmacology. According to data from OpenAlex, Zi-Yue Wan has authored 17 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 5 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Zi-Yue Wan's work include Renal Diseases and Glomerulopathies (4 papers), Inflammasome and immune disorders (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Zi-Yue Wan is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Inflammasome and immune disorders (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Zi-Yue Wan collaborates with scholars based in China, Japan and Malaysia. Zi-Yue Wan's co-authors include Yue Tu, Yi‐Gang Wan, Yinglu Liu, Bu-Hui Liu, Qi‐Jun Fang, Wei Wu, Renmao Tang, Haitao Tang, Meizi Wang and Yan Long and has published in prestigious journals such as Frontiers in Pharmacology, Phytomedicine and Aging.

In The Last Decade

Zi-Yue Wan

15 papers receiving 453 citations

Peers

Zi-Yue Wan
Comparison fields: 5 of 69
  • Molecular Biology 248
  • Nephrology 153
  • Epidemiology 56
  • Immunology 47
  • Surgery 42
Replace Bu-Hui Liu with:
Bu-Hui Liu China
Yilan Shen China
Yanru Huang China
Enchao Zhou China
Xisheng Xie China
Yuebo Huang China
Hengjiang Guo China
Shuang Chu China
Montserrat B. Duran-Salgado Mexico
Bu-Hui Liu China View profile →
Citations per field, relative to Zi-Yue Wan
Zi-Yue Wan · 1×
Citations per year, relative to Zi-Yue Wan
Zi-Yue Wan · 1×

Countries citing papers authored by Zi-Yue Wan

Since Specialization
Citations

This map shows the geographic impact of Zi-Yue Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi-Yue Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi-Yue Wan more than expected).

Fields of papers citing papers by Zi-Yue Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi-Yue Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi-Yue Wan. The network helps show where Zi-Yue Wan may publish in the future.

Co-authorship network of co-authors of Zi-Yue Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Zi-Yue Wan. A scholar is included among the top collaborators of Zi-Yue Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi-Yue Wan. Zi-Yue Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
# Work Indexed citations
1 0
2 0
3 1
4 47
5 28
6 14
7 2
8 81
9 36
10
Shenkang injection, a modern preparation of Chinese patent medicine, diminishes tubulointerstitial fibrosis in obstructive nephropathy via targeting pericyte-myofibroblast transition.
17
11 10
12 2
13 92
14 60
15 3
16 61
17 3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026